Breast: Genetic Mutations
BRCA Genes
Definition
- Tumor Suppressor Genes
- Loss of Function Mutations Cause Increased Risk of Cancer
- Higher Prevalence in Ashkenazi Jewish, Icelandic & French-Canadian Populations
Screening Indications

BRCA Genes 1
Breast & Ovarian Cancer
- BRCA1 Breast Cancers Have Higher Risk for Being Hormone Receptor Negative
- BRCA2 Significantly Increases Risk for Male Breast Cancer Mn
| BRCA1 | BRCA2 | |
| Breast CA (Female) | 55-70% | 45-70% |
| Ovarian CA | 40-45% | 15-20% |
| Breast CA (Male) | 1% | 7-10% |
Other Cancers
- Pancreatic Cancer
- BRCA1 – 2.26 Relative Risk & 1% Absolute Risk
- BRCA2 – 3.51 Relative Risk & 4.9% Absolute Risk
- Prostate Cancer
- BRCA1 – 3-4 Relative Risk & 15-20% Absolute Risk
- BRCA2 – 5-9 Relative Risk & 30-40% Absolute Risk
- Other Gynecologic Cancers:
- Fallopian Tube
- Endometrial (Conflicting Date & Increased Risk is Uncertain)
- Other Cancers:
- Primary Peritoneal Carcinoma
- Colorectal Cancer
- Skin Cancer (Melanoma, etc.)
- Stomach Cancer
- Biliary Cancers
PALB2 (Partner and Localizer of BRCA2)
Basics
- Encodes for an Interacting Protein Critical for BRCA2 Tumor Suppression Activity
- Increases Risk of Breast Cancer
- Also Increases Risk for Ovarian, Pancreas & Prostate Cancer
Relative Risk of Breast Cancer
- Age < 40: 8-9x
- Age 40-60: 6-8x
- Age > 60: 5x
Genetic Syndromes
Genetic Syndromes
- Li-Fraumeni Syndrome (TP53)
- Peutz-Jeghers Syndrome (STK11)
- Cowden/PTEN Hamartoma Syndrome (PTEN)
- Hereditary Diffuse Gastric Cancer Syndrome (CDH1)
- Lynch Syndrome (MSH1, MLH1, MSH6, PMS2 & EPCAM)
- Ataxia Telangiectasia (ATM)
- Muir-Torre Syndrome (MLH1 & MSH2)
Mnemonics
BRCA2 Increases Risk in Males
- 2 Testicles: Type 2 Affects Men (Male Breast & Prostate Cancer)
References
- Tessssa 13. Wikimedia Commons. (License: CC BY-SA-4.0)